Research output per year
Research output per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Related documents
External positions
Professor, Faculty of Pharmaceutical Sciences, Teikyo University
Apr 2018 → …
associate professor, Faculty of Pharmaceutical Sciences, Teikyo University
Jul 2009 → Mar 2018
Research Fields
- Clinical pharmacy
Fingerprint
Dive into the research topics where FUMIO ITAGAKI is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
The Association Between Deep Vein Thrombosis, Pulmonary Embolism, and Janus Kinase Inhibitors: Reporting Status and Signal Detection in the Japanese Adverse Drug Event Report Database
Maeshima, T., Aisu, S., Ohkura, N., Watanabe, M. & Itagaki, F., Sep 2024, In: Drugs - Real World Outcomes. 11, 3, p. 369-375 7 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
がん薬物療法に関わるバイオマーカー 分子標的薬・免疫チェックポイント阻害薬の効果予測バイオマーカー
文雄板垣, Nov 2024, In: 医薬品情報. 3, p. 15-22Research output: Contribution to journal › Comment/debate
-
-
ビタミンK非依存的な機序で血液凝固に影響を与える可能性のある抗菌薬の探索
直樹大藏, 真由永久保, 理代鎌田, 多絵前島, 勇一神窪, 亮介飯島 & 文雄板垣, May 2024, In: 日本血栓止血学会誌. 35, 2, p. 325Research output: Contribution to journal › Conference article › peer-review
-
分子標的治療薬における副作用情報のマッピングと特定有害事象に着目した薬剤間の横断的解析
文雄板垣, ひかり齋藤, 澪香立田, 七海戸辺, 多絵前島, 義弘岩本 & 真知子渡邊, May 2024, In: 日本臨床腫瘍薬学会雑誌. 36, p. 429Research output: Contribution to journal › Conference article › peer-review